Sportradar posts robust 19% revenue surge
Sportradar (NASDAQ:SRAD) reported Q2 revenue of €378 million, up 19%, while adjusted EBITDA increased 19% to €76 million.
Sportradar (NASDAQ:SRAD) reported Q2 revenue of €378 million, up 19%, while adjusted EBITDA increased 19% to €76 million.
Ocular Therapeutix (NASDAQ:OCUL) reported Q2 revenue of $13.5 million and plans a Q4 AXPAXLI filing after FDA alignment.
Krystal Biotech (NASDAQ:KRYS) reported Q2 VYJUVEK revenue of $119.2 million, up 24%, and net income of $54.8 million.
Hess Midstream (NYSE:HESM) reported Q2 revenue of $399 million, net income of $173.7 million and adjusted free cash flow of $231.6 million.
Compugen (NASDAQ:CGEN) reported Q2 revenue of $2.6 million and said its $125.3 million cash position could fund operations into 2029.
Tyson Foods (NYSE:TSN) announced its financial results for the fiscal third quarter of 2026, reporting flat sales of $13.87 billion.
Lindblad Expeditions Holdings (NASDAQ:LIND) reported Q2 tour revenue of $199.2 million, up 19% year over year.
Marriott International (NASDAQ:MAR) announced its second-quarter 2026 financial results, reporting an adjusted net income of $844 million.
Indivior Pharmaceuticals (NASDAQ:INDV) reported Q2 revenue of $343 million, up 14%, and announced an all-stock Supernus merger.
Brookfield Asset Management (NYSE:BAM) completed its Oaktree acquisition, combining both credit platforms into a $365 billion global franchise.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy